Q2 2024 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2024-08-13 · accession 0001172661-24-003270
$570.2M
Reported value
26
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $53.4M | 9.36% | 167,499 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $51.3M | 9.00% | 474,114 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $46.9M | 8.22% | 149,590 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $44.3M | 7.76% | 86,900 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $38.2M | 6.70% | 88,890 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $34.4M | 6.04% | 513,700 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $33.3M | 5.83% | 318,754 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $31.3M | 5.48% | 275,718 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $25.8M | 4.52% | 121,895 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $23.0M | 4.03% | 544,200 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $21.6M | 3.78% | 524,500 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $20.0M | 3.51% | 132,861 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $19.1M | 3.35% | 231,800 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $18.5M | 3.25% | 76,256 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $18.3M | 3.21% | 136,603 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $18.1M | 3.18% | 626,909 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $15.7M | 2.75% | 257,089 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $14.3M | 2.50% | 330,830 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $12.6M | 2.21% | 28,290 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $10.6M | 1.87% | 197,000 | PUT | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $9.7M | 1.70% | 462,911 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.5M | 0.61% | 43,200 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.4M | 0.42% | 45,000 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $1.7M | 0.30% | 700,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.6M | 0.28% | 46,300 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $816,516 | 0.14% | 53,124 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.